Results 91 to 100 of about 578,438 (161)
Hairy Cell Leukemia: Clinical Characteristics and Outcomes from a Single Center in the Middle East and North Africa
Journal of Blood MedicineShehab Mohamed,1 Mohamad Wajeh Dulli,2 Abdulrahman Al-Mashdali,1 Rola Ghasoub,3 Mohammed Abdulgayoom,1 Honar Cherif,1 Susanna Akiki,4,5 Anil Elahie,1 Deena Mudawi,1 Hesham Elsabah,1 Mohamed Yassin,1 Noor Salah Moustafa,2 Leen Haj Saleh,5 Priyadarshini ...Mohamed S, Dulli MW, Al-Mashdali A, Ghasoub R, Abdulgayoom M, Cherif H, Akiki S, Elahie A, Mudawi D, Elsabah H, Yassin M, Moustafa NS, Haj Saleh L, Vatsayana PA, Kohla S, Ibrahim F, Soliman D +16 moredoaj PB2467: ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN 39 PATIENTS WITH NON-HODGKIN LYMPHOMA: LONG-TERM FOLLOW-UP IN A SINGLE CENTRE
HemaSphere, 2023 Fouzia Louar, Malek Benakli, Sabrina Akhrouf, Farih Mehdid, Nadia Rahmoune, Mounira Baazizi, Dina Ait Ouali, Hanane Bouarab, Sara Zerkout, Rihab Benouattas, Rose-Marie Hamladji, Redhouane Ahmed Nacer +11 moredoaj +1 more sourceBuilding blocks of hematology in the last 3 decades in Pakistan
Blood Advances, 2019 Tahir S. Shamsi, Tasneem Farzana, Saqib Ansari, Nazli Hossain, Arshi Naz, Munira Borhany, Mehwesh Taj, Saima Munzir, Uzma Zaidi, Jawwad Hassan, Nida Irfan, Nazmeen Shakoor, Farah Mubarak, Kouser Parveen, Syeda Anwari, Nadeem Ahmed, Mansoor Hussain, Irfan Ghafoor Baig, Dilnasheen Safdar, Sadaf Shahab +19 moredoaj +1 more sourcePB2426: SORAFENIB MAINTENANCE TAILORED TO FLT3-MUTATED AML AFTER ALLOGENEIC HCT IS HIGHLY FEASIBLE AND EFFECTIVE: A REAL-LIFE EXPERIENCE
HemaSphere, 2023 Elisa Diral, Giulia Furnari, Francesca Farina, Daniela Clerici, Sarah Marktel, Raffaella Greco, Gloria Catalano, Alessandro Bruno, Edoardo Campodonico, Elisabetta Xue, Sara Mastaglio, Luca Vago, Massimo Stefano Luca Bernardi, Matteo Giovanni Carrabba, Consuelo Corti, Jacopo Peccatori, Fabio Ciceri, Maria Teresa Lupo Stanghellini +17 moredoaj +1 more sourceTreatment of pediatric acute lymphoblastic leukemia in India on BFM 95 protocol backbone with relevant modifications and minimal residual disease application - Doable and effective
Pediatric Hematology Oncology Journal, 2022 Dhwanee Thakkar, K. Upasana, Sunisha Arora, Ritu Chadha, D.S. Udayakumar, Bhawna Jha, Anjali Yadav, Neha Rastogi, Shalini Goel, Renu Saxena, Satya Prakash Yadav +10 moredoaj +1 more source